We are live on
!
Find out more
GCM
Glenview Capital Management Portfolio holdings
AUM
$5.49B
1-Year Est. Return
46.89%
This Fund
S&P 500
This Quarter
Est. Return
+10.9%
1 Year Est. Return
+46.89%
3 Year Est. Return
+94.27%
5 Year Est. Return
+129.04%
10 Year Est. Return
+529.98%
AUM
$15.1B
AUM Growth
+$281M
(+1.9%)
Cap. Flow
-$1.17B
Cap. Flow
% of AUM
-7.73%
Top 10 Holdings %
Top 10 Hldgs %
50.83%
Holding
57
New
8
Increased
9
Reduced
27
Closed
5
Avg Time Held Equity + Options
6.3
quarters
Top 10 Avg Time Held Equity + Options
3.3
quarters
Top 20 Avg Time Held Equity + Options
7.1
quarters
Avg Time Held Equity only
6.4
quarters
Top 10 Avg Time Held Equity only
3.3
quarters
Top 20 Avg Time Held Equity only
7.1
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$188M |
| 2 |
Intel
INTC
|
+$178M |
| 3 |
SHPG
Shire pic
SHPG
|
+$177M |
| 4 |
Lowe's Companies
LOW
|
+$105M |
| 5 |
Hain Celestial
HAIN
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$327M |
| 2 |
Encompass Health
EHC
|
+$300M |
| 3 |
Labcorp
LH
|
+$210M |
| 4 |
Humana
HUM
|
+$206M |
| 5 |
Elevance Health
ELV
|
+$185M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.45% |
| 2 | Technology | 11.76% |
| 3 | Materials | 11.61% |
| 4 | Communication Services | 10.45% |
| 5 | Financials | 5.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
HCA Healthcare
HCA
$99.8B
| $1.27B | 8.42% |
14,265,265
-3,916,176
| -22% | -$327M |
2013 Q2
15 quarters
|
|
|
2
Humana
HUM
$50.5B
| $1.1B | 7.27% |
5,315,768
-998,022
| -16% | -$206M |
2013 Q2
15 quarters
|
|
|
3
Elevance Health
ELV
$92.2B
| $779M | 5.17% |
4,711,645
-1,162,404
| -20% | -$185M |
2014 Q1
12 quarters
|
|
|
4
DuPont de Nemours
DD
$17.5B
| $754M | 5% |
4,684,922
+1,210,725
| +35% | +$188M |
2014 Q3
10 quarters
|
|
5
FMC
FMC
$1.29B
| $736M | 4.88% |
12,196,000
+1,187,366
| +11% | +$61.4M |
2015 Q1
8 quarters
|
|
6
Cigna
CI
$74.7B
| $719M | 4.77% |
4,905,428
-756,658
| -13% | -$112M |
2013 Q2
15 quarters
|
|
|
AET
7
DELISTED
Aetna Inc
AET
| $641M | 4.26% |
5,029,073
-164,991
| -3% | -$20.7M |
2013 Q4
13 quarters
|
|
|
CSC
8
DELISTED
Computer Sciences
CSC
| $574M | 3.81% |
8,320,463
-334,793
| -4% | -$22.2M |
2015 Q4
5 quarters
|
|
9
IQVIA
IQV
$42.9B
| $555M | 3.69% |
6,897,637
-29,698
| -0.4% | -$2.32M |
2016 Q2
3 quarters
|
|
10
Alphabet (Google) Class A
GOOGL
$4.33T
| $537M | 3.56% |
12,667,360
-2,604,740
| -17% | -$110M |
2015 Q4
5 quarters
|
|
11
Flex
FLEX
$41B
| $529M | 3.51% |
41,773,550
-7,551,822
| -15% | -$90.4M |
2013 Q2
15 quarters
|
|
12
AbbVie
ABBV
$485B
| $476M | 3.16% |
7,301,967
-1,815,002
| -20% | -$114M |
2015 Q1
8 quarters
|
|
13
Thermo Fisher Scientific
TMO
$245B
| $457M | 3.03% |
2,972,060
-687,674
| -19% | -$105M |
2013 Q2
15 quarters
|
|
14
Apple
AAPL
$4.98T
| $452M | 3% |
12,573,032
-39,348
| -0.3% | -$1.3M |
2016 Q3
2 quarters
|
|
|
15
Lowe's Companies
LOW
$106B
| $448M | 2.97% |
5,452,659
+1,376,540
| +34% | +$105M |
2016 Q4
1 quarter
|
|
|
16
Labcorp
LH
$25.4B
| $382M | 2.54% |
3,102,046
-1,773,089
| -36% | -$210M |
2015 Q2
7 quarters
|
|
17
DELISTED
Paramount Global Class B
PARA
| $380M | 2.52% |
5,471,963
+343,424
| +7% | +$22.5M |
2013 Q2
15 quarters
|
|
18
Tenet Healthcare
THC
$21.5B
| $317M | 2.1% |
17,890,230
| – | – |
2013 Q2
15 quarters
|
|
19
Liberty Global Class A
LBTYA
$2.92B
| $279M | 1.85% |
7,783,565
-36,794
| -0.5% | -$1.3M |
2014 Q2
11 quarters
|
|
20
Avis
CAR
$3.8B
| $245M | 1.63% |
8,298,004
| – | – |
2014 Q1
12 quarters
|
|
21
Williams Companies
WMB
$91.2B
| $214M | 1.42% |
7,241,362
-1,198,596
| -14% | -$34.7M |
2016 Q2
3 quarters
|
|
22
Universal Health Services
UHS
$10.6B
| $213M | 1.42% |
1,714,464
-48,451
| -3% | -$5.73M |
2016 Q3
2 quarters
|
|
23
Liberty Global Class C
LBTYK
$2.87B
| $204M | 1.35% |
5,824,640
-16,304
| -0.3% | -$562K |
2014 Q2
11 quarters
|
|
24
Brookdale Senior Living
BKD
$2.42B
| $198M | 1.31% |
14,730,718
-1,899,697
| -11% | -$26.8M |
2014 Q2
11 quarters
|
|
25
DELISTED
Anywhere Real Estate
HOUS
| $188M | 1.25% |
6,301,426
-700,159
| -10% | -$19M |
2014 Q3
10 quarters
|
|
Similar funds
GCM
VCM
ACM
MC
SCM
NC
EI
AP
Glenview Capital Management's Q1 2017 Portfolio in Review
As of Q1 2017, Glenview Capital Management held 57 positions worth $15.1B, up 1.9% from $14.8B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Glenview Capital Management withdrew a net $1.17B in Q1 2017, closing 5 positions and reducing 27 holdings. Its most notable exit was Encompass Health, an estimated $300M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 52% a quarter earlier, followed by Technology and Materials.
Against the trend, Glenview Capital Management opened a new position in Intel worth $178M.
- Glenview Capital Management's largest Q1 2017 buy was Intel: 4,931,557 shares worth $178M.
- Glenview Capital Management added most to DuPont de Nemours in Q1 2017, an estimated $188M increase.
- Glenview Capital Management's biggest Q1 2017 reduction was HCA Healthcare, cutting an estimated $327M.
- Glenview Capital Management fully exited Encompass Health in Q1 2017, selling an estimated $300M.
- Glenview Capital Management's ten largest holdings make up 51% of its $15.1B portfolio in Q1 2017.
- Glenview Capital Management opened 8 new positions and closed 5 in Q1 2017.
- Glenview Capital Management's portfolio value rose 1.9% quarter-over-quarter to $15.1B.
Based on Glenview Capital Management's 13F filing for Q1 2017, filed 15 May 2017.